![]() Emergent Biosolutions Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats. | ![]() Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Gaithersburg, US HQ Mississauga, CA Winnipeg, CA Dublin, IE London, GB Canton, US Lansing, US see more | |
Employees | Employees 90044% decrease | Employees 713 |
Valuation ($) | Valuation ($) 493.6 m | Valuation ($) 482.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $742.9m (FY, 2025) | Revenue (est.) €157.9m (FY, 2025) |
Cost of goods | Cost of goods $326.2m (FY, 2025) | Cost of goods €8.2m (FY, 2025) |
Gross profit | Gross profit $416.7m (FY, 2025) | Gross profit €177.7m (FY, 2025) |
Net income | Net income $52.6m (FY, 2025) | Net income (€115.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 34.5m | Total funding raised $ 51.7m |

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.
View company